An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype

作者:Chuang Ming Kai; Chiu Yu Chiao; Chou Wen Chien*; Hou Hsin An; Tseng Mei Hsuan; Kuo Yi Yi; Chen Yidong; Chuang Eric Y; Tien Hwei Fang
来源:Oncotarget, 2015, 6(36): 39098-39110.
DOI:10.18632/oncotarget.5390

摘要

Although clinical features, cytogenetics, and mutations are widely used to predict prognosis in patients with acute myeloid leukemia (AML), further refinement of risk stratification is necessary for optimal treatment, especially in cytogenetically normal (CN) patients. We sought to generate a simple gene expression signature as a predictor of clinical outcome through analyzing the mRNA arrays of 158 de novo CN AML patients. We compared the gene expression profiles of patients with poor response to induction chemotherapy with those who responded well. Forty-six genes expressed differentially between the two groups. Among them, expression of 11 genes was significantly associated with overall survival (OS) in univariate Cox regression analysis in 104 patients who received standard intensive chemotherapy. We integrated the z-transformed expression levels of these 11 genes to generate a risk scoring system. Higher risk scores were significantly associated with shorter OS (median 17.0 months vs. not reached, P < 0.001) in ours and another 3 validation cohorts. In addition, it was an independent unfavorable prognostic factor by multivariate analysis (HR 1.116, 95% CI 1.035 similar to 1.204, P = 0.004). In conclusion, we developed a simple mRNA expression signature for prognostication in CN-AML patients. This prognostic biomarker will help refine the treatment strategies for this group of patients.

  • 出版日期2015-11-17